Mark your calendars for Wednesday 6th November 2024, as Revolution Medicines (NASDAQ: RVMD) is set to unveil its third quarter financial results. This highly anticipated announcement will be made after market close, giving investors and market participants a chance to assess the company's financial performance.
According to the predictions of financial experts on Wall Street, the business is expected to announce an anticipated $0.89 loss per share for the quarter. Further, the firm is poised to disclose a total revenue of $0.75 million for the period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $1.4 million. Additionally, they forecast the earnings per share to hit loss of $3.38 for the fiscal year.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $0.99.
[stock_market_widget type=”chart” template=”line2″ assets=RVMD range=”1y” interval=”1wk” price_field=”close” heading=”{symbol}” line_width=”2″ gradient_direction=”bottom” gradient_size=”1″ line_color=”#1b6dc1″ area_background_color=”#1b6dc1″ area_background_color2=”#ffffff” axes_color=”#000000″ tooltip_text_color=”#262626″ tooltip_background_color=”#ffffff” range_selector=”false” volume_enabled=”false” axes_enabled=”true” tooltip_enabled=”false” events_enabled=”false” smoothing_enabled=”true” zoom_enabled=”false” save_image_enabled=”false” api=”yahoo-finance”]
RVMD will host a conference call with investment community on 6th November 2024 at 04:30 PM eastern time to discuss the financial results.
Revolution Medicines (RVMD) closed Friday's regular trading session at $55.09, showing a 2.97 percent advance. During the day, RVMD shares traded between $53.43 and $55.20, with a day volume of 1.38 million shares.
